XML 41 R29.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue
 9 Months Ended
Dec. 31, 2022
Revenue From Contract With Customer [Abstract]  
Revenue

23. REVENUE

Revenue is disaggregated as follows:

 

 

 

Three months ended

 

 

Nine months ended

 

 

 

December 31,

 

 

December 31,

 

 

December 31,

 

 

December 31,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Canada cannabis

 

 

 

 

 

 

 

 

 

 

 

 

Canadian adult-use cannabis

 

 

 

 

 

 

 

 

 

 

 

 

Business-to-business1

 

$

21,522

 

 

$

33,282

 

 

$

73,379

 

 

$

117,902

 

Business-to-consumer

 

 

11,036

 

 

 

14,477

 

 

 

36,243

 

 

 

48,473

 

 

 

 

32,558

 

 

 

47,759

 

 

 

109,622

 

 

 

166,375

 

Canadian medical cannabis2

 

 

14,059

 

 

 

12,919

 

 

 

41,714

 

 

 

39,504

 

 

 

$

46,617

 

 

$

60,678

 

 

$

151,336

 

 

$

205,879

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rest-of-world cannabis

 

 

 

 

 

 

 

 

 

 

 

 

C3

 

 

-

 

 

 

9,675

 

 

 

-

 

 

 

33,005

 

Other rest-of-world cannabis

 

 

5,846

 

 

 

12,624

 

 

 

30,179

 

 

 

32,357

 

 

 

$

5,846

 

 

$

22,299

 

 

$

30,179

 

 

$

65,362

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Storz & Bickel

 

$

20,214

 

 

$

25,205

 

 

$

49,351

 

 

$

63,786

 

BioSteel

 

$

16,363

 

 

$

16,974

 

 

$

64,173

 

 

$

31,147

 

This Works

 

$

8,289

 

 

$

10,730

 

 

$

20,677

 

 

$

26,308

 

Other

 

 

3,884

 

 

 

5,086

 

 

 

13,475

 

 

 

16,073

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$

101,213

 

 

$

140,972

 

 

$

329,191

 

 

$

408,555

 

 

1Canadian adult-use business-to-business net revenue during the three and nine months ended December 31, 2022 reflects excise taxes of $10,797 and $33,754, respectively (three and nine months ended December 31, 2021 – $12,754 and $43,501, respectively).

2Canadian medical cannabis net revenue for the three and nine months ended December 31, 2022 reflects excise taxes of $1,339 and $3,625, respectively (three and nine months ended December 31, 2021 – $1,298 and $4,039, respectively).

 

 

The Company recognizes variable consideration related to estimated future product returns and price adjustments as a reduction of the transaction price at the time revenue for the corresponding product sale is recognized. Net revenue reflects actual returns and variable consideration related to estimated returns and price adjustments in the amount of $8,869 and $15,345 for the three and nine months ended December 31, 2022, respectively (three and nine months ended December 31, 2021 – $3,726 and $12,375, respectively). As of December 31, 2022, the liability for estimated returns and price adjustments was $2,937 (March 31, 2022 – $3,437).